Use these materials to raise awareness about new immunisation products to protect infants in early life from a top cause of severe respiratory infections in children.

ECDC has launched an online platform, RespiCompass, which uses mathematical modelling to simulate respiratory disease dynamics under different scenarios.

Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children.

Based on the current risk assessment, WHO advises against any travel or trade restrictions related to current trends in acute respiratory infections.

Tremendously exciting times and possibly underestimating the enormity of its impact. These are some of the comments we hear when experts share their insights on the recently available RSV vaccines.

This report covers the period from August 2023 to August 2024, highlighting the latest developments within the vaccine industry and how these innovations are addressing existing and upcoming health threats.

In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.

The new RSV vaccines are medical milestones. But what is owed to the families who unknowingly helped pave the way?

From being a largely unknown pathogen, RSV is now almost a household word. New solutions, such as long-acting monoclonal antibodies and maternal vaccination, both recently recommended by WHO, could dramatically alter the RSV landscape.

This Review provides an overview of RSV vaccines highlighting different target populations, antigens, and trial results. As RSV vaccines have not yet reached low-income and middle-income countries, next steps are outlined to minimise the delay.

ECDC’s annual conference took place from 20-22 November in Stockholm, bringing together hundreds of public health professionals—from epidemiologists to veterinarians, microbiologists, clinicians, and more.

Respiratory syncytial virus (RSV) is a leading cause of hospitalization among young children. Historically, American Indian and Alaska Native (AI/AN) children have experienced high rates of RSV-associated hospitalization.